Johnathan Beth (@johnathan_beth) 's Twitter Profile
Johnathan Beth

@johnathan_beth

ID: 802791544444973056

calendar_today27-11-2016 08:29:54

1,1K Tweet

67 Followers

1,1K Following

Science Immunology (@sciimmunology) 's Twitter Profile Photo

A new Science #Immunology study demonstrates that loss of the ubiquitin ligase #Riplet induces terminal exhaustion of CD8 #Tcells and promotes resistance to anti–PD-1 treatment in mouse models of hepatocellular #carcinoma. scim.ag/4nkicmP

A new Science #Immunology study demonstrates that loss of the ubiquitin ligase #Riplet induces terminal exhaustion of CD8 #Tcells and promotes resistance to anti–PD-1 treatment in mouse models of hepatocellular #carcinoma. scim.ag/4nkicmP
NEJM (@nejm) 's Twitter Profile Photo

In the latest video in our partnership with Dr. Glaucomflecken, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free:

Science Immunology (@sciimmunology) 's Twitter Profile Photo

Scientists have identified an isoform of the Type2 #cytokine receptor subunit IL13Rα1 that can fine tune immune responses and may underlie varied susceptibility to #allergic disease. The Francis Crick Institute Imperial College London Learn more in Science #Immunology: scim.ag/4ko0Lzh

Scientists have identified an isoform of the Type2 #cytokine receptor subunit IL13Rα1 that can fine tune immune responses and may underlie varied susceptibility to #allergic disease. <a href="/TheCrick/">The Francis Crick Institute</a> <a href="/imperialcollege/">Imperial College London</a>

Learn more in Science #Immunology: scim.ag/4ko0Lzh
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Online Now: KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TLrhCk

Online Now: KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer dlvr.it/TLrhCk
Science Immunology (@sciimmunology) 's Twitter Profile Photo

New research in mice published in Science #Immunology identifies the Spi-B–c-Kit–TSLP pathway in #TuftCells as a potential therapeutic target to reduce the severity of food #allergies and other type 2 inflammatory disorders. scim.ag/3I4sEyV

New research in mice published in Science #Immunology identifies the Spi-B–c-Kit–TSLP pathway in #TuftCells as a potential therapeutic target to reduce the severity of food #allergies and other type 2 inflammatory disorders. scim.ag/3I4sEyV
Science Immunology (@sciimmunology) 's Twitter Profile Photo

Scientists show that paired analysis of #CD69 mRNA and protein levels can help identify potent CD8 T cells with enhanced #cytotoxic effector functions within exhausted populations in tumors. Arja Ray Max Learn more in Science #Immunology: scim.ag/3Ik4aBL

Scientists show that paired analysis of #CD69 mRNA and protein levels can help identify potent CD8 T cells with enhanced #cytotoxic effector functions within exhausted populations in tumors. <a href="/RayArja/">Arja Ray</a> <a href="/MaxKrummel/">Max</a>

Learn more in Science #Immunology: scim.ag/3Ik4aBL
NEJM (@nejm) 's Twitter Profile Photo

In the BATURA phase 3b trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results and Research Summary:

In the BATURA phase 3b trial, as-needed albuterol–budesonide resulted in a lower risk of severe asthma exacerbation than as-needed albuterol among participants with disease that was uncontrolled despite treatment for mild asthma. Full trial results and Research Summary:
Science Immunology (@sciimmunology) 's Twitter Profile Photo

A new Science #Immunology study identifies CD8 #Tcells with enhanced effector function in tumors, which could be leveraged for #cancer treatments. scim.ag/3Ik4aBL

A new Science #Immunology study identifies CD8 #Tcells with enhanced effector function in tumors, which could be leveraged for #cancer treatments. scim.ag/3Ik4aBL
Cell Press (@cellpressnews) 's Twitter Profile Photo

Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Samuel Klein of WUSTLnews reports in Cell Metabolism #ENDO2025 hubs.li/Q03wtLK-0

Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb
David Gandara (@drgandara) 's Twitter Profile Photo

At NOSCM, Julia Rotow MD presents provocative data supporting continuation of EGFR TKIs after progressive disease, so-called treatment beyond progression (TBP). I am increasingly a believer. Invariably there are residual sensitive clones which need to be controlled

At NOSCM, <a href="/JuliaRotow/">Julia Rotow MD</a>  presents provocative data supporting continuation of EGFR TKIs after progressive disease, so-called treatment beyond progression (TBP). I am increasingly a believer. Invariably there are residual sensitive clones which need to be controlled